Health, Vaccines, Lyme Disease, FDA, Medicine.
response. Then, they combined those variations of epitopes into one single protein. They call it a chimeritope. This became a core component of a canine vaccine, called Vanguard crLyme, that the FDA approved in 2016. In that vaccine, both OspC and OspA antibodies work in concert to kill bacteria